Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genome.

Ähnliche Einträge

• Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element.
  von: Li, G, et al.
  Veröffentlicht: (1993)
• Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells.
  von: Matsukura, M, et al.
  Veröffentlicht: (1989)
• Inhibition of human immunodeficiency virus in early infected and chronically infected cells by antisense oligodeoxynucleotides and their phosphorothioate analogues.
  von: Agrawal, S, et al.
  Veröffentlicht: (1989)
• Antimycobacterial activities of antisense oligodeoxynucleotide phosphorothioates in drug-resistant strains.
  von: Rapaport, E, et al.
  Veröffentlicht: (1996)
• Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity.
  von: Thierry, A R, et al.
  Veröffentlicht: (1992)